Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Komipharm International Co., Ltd. (041960)
Market Open
11 Aug, 06:30
KRX SM
All
(1)
KR
(1)
KRX SM
Primary
₩
9,270.
00
+320
+3.5754%
₩
567.88B
Market Cap
-
P/E Ratio
-
Div Yield
136,714
Volume
-
Eps
₩
8,950
Previous Close
Watching
Watch
Add Transaction
Day Range
8,870
9,280
Year Range
5,250
10,790
Want to track
041960
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Earnings
Splits
Statistics
Historical Data
Komipharm International Co., Ltd. (041960) Statistics
Valuation metrics
Market Cap
567.88B
Enterprise value
619.67B
Trailing P/E (ttm)
-93.04
Forward P/E
-
PEG ratio
1.15
Price/Sales (ttm)
11.96
Price/Book (mrq)
8.45
Enterprise Value/Revenue
12.4
Enterprise Value/EBITDA
-2,049.26
Overview
Shares outstanding
57.81M
Float
-
Shares short
-
% Held by insiders
-
% Held by institutions
-
Average volume (10 days)
229.49K
Average volume (90 days)
250.54K
Price summary
52-Week low
5,250
52-Week high
10,790
Beta
-
50-Day moving average
7,468.57
200-Day moving average
8,126.89
Dividends and splits
Forward annual dividend rate
23.06
Forward annual dividend yield
0.0029%
Trailing annual dividend rate
23.96
Trailing annual dividend yield
0.003%
5-Year annual dividend yield
-
Payout ratio
-
Dividend Date
-
Ex-Dividend Date
-
Last split factor
1:1
Last split Date
17 Aug 2023
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Mar 2026
Profitability
Profit margin
-0.13%
Operating margin
0.02%
Operational effectiveness
Return on assets
-0.05%
Return on equity
-0.09%
Income Statement
Revenue (ttm)
52.47B
Revenue per share (ttm)
695.14
Quarterly revenue growth (yoy)
0%
Gross profit (ttm)
17.06B
EBITDA
6.13B
Net income to common (ttm)
-7.21B
Diluted EPS (ttm)
-88.96
Quarterly earnings growth (yoy)
-0.17%
Balance Sheet
Total cash (mrq)
5.13M
Total cash per share (mrq)
341.22
Total debt (mrq)
40.22B
Total Debt/Equity (mrq)
0.57
Current ratio (mrq)
1.31%
Book value per share (mrq)
1,019.54
Cash Flow
Cash flow statement
-9.79B
Levered free cash flow (LFCF)
-7.21B